Susceptibility Testing and Molecular Classification of Paecilomyces spp
- 2008-08
- Antimicrobial Agents and Chemotherapy 52(8)
- PubMed: 18519716
- DOI: 10.1128/AAC.00538-08
Study Design
- Methods
- In vitro experiment
- Highly Cited
Abstract
In vitro susceptibility profiles of 58 Paecilomyces clinical isolates are reported. Amphotericin B, itraconazole, and echinocandins showed poor activity against Paecilomyces lilacinus, while the new triazoles were active against it. Paecilomyces variotii exhibited a different susceptibility pattern, being susceptible to most antifungal agents apart from voriconazole and ravuconazole.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|